Junior Strength Pain Relief

Description

Acetaminophen is formulated as a fast-dissolving tablet, each containing 160 mg of the active ingredient. This medication is indicated for children ages 6 to 11 and serves as both a fever reducer and pain reliever. The product is free from aspirin and is designed to melt in the mouth for ease of administration. Each package contains 24 tablets, which are flavored with grape to enhance palatability.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with the common cold, flu, and headache. Additionally, it is indicated for the temporary reduction of fever.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The recommended dosage of this product is determined primarily by the patient's weight or age. Healthcare professionals should refer to the dosage chart below to identify the appropriate dose. It is essential to adhere to the recommended dosing guidelines and not exceed the maximum dosage to avoid potential overdose.

For patients weighing under 48 pounds or those under 6 years of age, it is advised to consult a physician before administration. For patients weighing between 48 and 59 pounds, the recommended dose is 2 tablets. For those weighing 60 to 71 pounds, the dosage increases to 2.5 tablets. Patients weighing between 72 and 95 pounds should receive 3 tablets, while those weighing 96 pounds and over may take 4 tablets.

In terms of age-based dosing, children aged 6 to 8 years should receive 2 tablets, while those aged 9 to 10 years should take 2.5 tablets. A dosage of 3 tablets is appropriate for children aged 11 years, and those aged 12 years may take 4 tablets.

The tablets should be dissolved in the mouth or chewed thoroughly before swallowing. If necessary, the dose may be repeated every 4 hours; however, it is crucial not to exceed 5 doses within a 24-hour period.

Contraindications

Use of this product is contraindicated in patients who are concurrently using any other product that contains acetaminophen, whether prescription or nonprescription. The risk of acetaminophen overdose may increase, leading to potential hepatotoxicity. If there is uncertainty regarding the presence of acetaminophen in other medications, consultation with a healthcare professional is advised.

Warnings and Precautions

This product contains acetaminophen, which poses a significant risk of severe liver damage if the maximum daily dosage is exceeded. Specifically, healthcare professionals should advise caregivers that liver damage may occur if a child takes more than five doses within a 24-hour period or if acetaminophen is used concurrently with other medications containing acetaminophen.

Healthcare providers should exercise caution and recommend that caregivers consult a physician prior to administration if the child has a history of liver disease. Additionally, it is important to inquire about any concurrent use of anticoagulants, such as warfarin, as this may necessitate further evaluation and monitoring.

Patients should be instructed to discontinue use and seek medical advice if any of the following occur: the emergence of new symptoms, the presence of redness or swelling, worsening pain that persists beyond five days, or a fever that intensifies or lasts longer than three days. These symptoms may indicate a need for further assessment and intervention.

In the event of an overdose, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay. Prompt medical attention is crucial, even if the patient does not exhibit any immediate signs or symptoms of overdose.

Side Effects

Severe liver damage may occur in patients taking this product containing acetaminophen if they exceed five doses within a 24-hour period, which is the maximum daily amount, or if they use it concurrently with other medications containing acetaminophen.

In cases of overdose, which may result from taking more than the recommended dose, liver damage can occur. Patients are advised to seek medical help or contact a Poison Control Center immediately, as prompt medical attention is critical, even if no signs or symptoms are present.

Patients should discontinue use and consult a healthcare professional if new symptoms arise, if redness or swelling occurs, if pain worsens or persists for more than five days, or if fever intensifies or lasts for more than three days.

It is recommended that patients consult a doctor before using this product if their child has liver disease or is taking the blood-thinning medication warfarin.

Drug Interactions

Patients should consult a healthcare professional prior to using this medication if they are concurrently taking warfarin, a blood-thinning agent. The combination may increase the risk of bleeding due to potential pharmacodynamic interactions.

Additionally, this medication should not be used in conjunction with any other products that contain acetaminophen, whether prescription or nonprescription. The risk of acetaminophen overdose and associated hepatotoxicity may be heightened. If there is uncertainty regarding the presence of acetaminophen in other medications, it is advisable to seek guidance from a healthcare provider.

Packaging & NDC

Below are the non-prescription pack sizes of Junior Strength Pain Relief (acetaminophen). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 6 to 11 years are the intended population for this product. The recommended dosing varies by weight and age: for children under 6 years, consultation with a doctor is advised; for those aged 6 to 8 years, the dosage is 2 tablets; for ages 9 to 10 years, 2-1/2 tablets; for 11 years, 3 tablets; and for patients 12 years and older, 4 tablets. It is important not to exceed 5 doses within a 24-hour period.

Healthcare professionals should advise parents to consult a doctor before use if their child has liver disease or is taking the anticoagulant warfarin. An overdose warning is in place, as exceeding the recommended dosage may lead to liver damage. In the event of an overdose, immediate medical assistance or contact with a Poison Control Center is crucial, even if no symptoms are present.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those planning to become pregnant should not use this medication. It is essential for these individuals to consult a healthcare professional prior to use. There is an increased risk of liver damage in pregnant individuals if the recommended dose is exceeded. Therefore, careful consideration and adherence to dosing guidelines are crucial to minimize potential risks to both the patient and the fetus. Additionally, breastfeeding is contraindicated during the use of this medication.

Lactation

Lactating mothers should consult a doctor before using this product. There is a potential for excretion in breast milk. The effects of acetaminophen on a nursing infant are not well studied; therefore, caution is advised.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment should consult a healthcare professional prior to use, particularly if they have a history of liver disease. It is critical to adhere to the recommended dosage, as exceeding this may lead to liver damage. Specifically, severe liver damage can occur if a patient takes more than five doses within a 24-hour period, which is the maximum daily allowance. Additionally, caution is advised when this product is used concurrently with other medications containing acetaminophen, as this combination may also result in severe liver damage. Regular monitoring of liver function may be warranted in patients with compromised liver function to ensure safety and efficacy.

Overdosage

In the event of an overdose, defined as the ingestion of more than the recommended dose, there is a significant risk of liver damage. Healthcare professionals should be aware that the severity of the effects may not be immediately apparent, as symptoms can be delayed or absent initially.

It is imperative that individuals who suspect an overdose seek medical assistance promptly. Contacting a Poison Control Center or obtaining medical help without delay is crucial for effective management. Quick medical attention is essential, even in the absence of noticeable signs or symptoms, to mitigate potential complications and ensure appropriate treatment is administered.

Healthcare providers should remain vigilant and prepared to assess and manage the situation, as timely intervention can be critical in preventing serious outcomes associated with overdose.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the provided text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. It is important to inform patients not to use this product in conjunction with any other medications that contain acetaminophen, whether prescription or nonprescription. If patients are uncertain about the presence of acetaminophen in their other medications, they should be encouraged to consult with a doctor or pharmacist for clarification.

Patients should be instructed to discontinue use and seek medical advice if they experience new symptoms, or if they notice any redness or swelling. Additionally, they should be advised to stop using the product and consult a healthcare professional if their pain worsens or persists for more than five days, or if their fever intensifies or lasts longer than three days.

For pediatric patients, healthcare providers should recommend that parents or guardians consult a doctor before using the medication if their child has liver disease. Furthermore, it is essential to advise them to speak with a doctor or pharmacist before use if their child is currently taking the blood-thinning medication warfarin.

Storage and Handling

The product is supplied in blister packaging. It should be stored at a temperature range of 20-25ºC (68-77ºF) and must be kept away from high humidity environments. Additionally, the product should be protected from light to maintain its integrity. Healthcare professionals are advised not to use the product if the blister unit is broken or shows any signs of tampering.

Additional Clinical Information

The medication is administered orally. Clinicians should advise patients to consult a doctor before use if the patient has liver disease. Additionally, it is important to seek guidance from a doctor or pharmacist if the patient is concurrently taking the blood-thinning medication warfarin. Patients should be instructed to discontinue use and contact a healthcare professional if new symptoms arise, if there is redness or swelling, if pain worsens or persists beyond five days, or if fever intensifies or lasts more than three days.

Drug Information (PDF)

This file contains official product information for Junior Strength Pain Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)